Onderneming Summit Therapeutics plc London S.E.
Aandelen
GB00BN40HZ01
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11-11-20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01-12-19 |
Director of Finance/CFO | 46 | 01-12-19 | |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16-10-23 |
Dave Gancarz
IRC | Investor Relations Contact | - | 01-11-20 |
Bhaskar Anand
AUD | Comptroller/Controller/Auditor | 46 | - |
Campbell Hair
HRO | Human Resources Officer | - | 01-10-20 |
Betty Chang
PRN | Corporate Officer/Principal | - | 01-06-21 |
Urte Gayko
LAW | General Counsel | 53 | 03-11-21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01-12-19 |
Robert Booth
BRD | Director/Board Member | 70 | 28-09-22 |
Director of Finance/CFO | 46 | 01-12-19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11-11-20 |
Mostafa Ronaghi
BRD | Director/Board Member | 55 | 11/04 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07-10-21 |
Director/Board Member | 63 | 15-11-22 | |
Urte Gayko
LAW | General Counsel | 53 | 03-11-21 |
Michelle Xia
BRD | Director/Board Member | 57 | 16-01-23 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 13-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 701 979 596 | 83 228 173 ( 11,86 %) | 0 | 11,86 % |
Bedrijfsgegevens
![Adres Summit Therapeutics plc](https://cdn.zonebourse.com/static/address/18044789.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,15% | 124 mld. | |
+18,02% | 112 mld. | |
+5,07% | 22,94 mld. | |
-12,75% | 22,22 mld. | |
-9,86% | 17,02 mld. | |
-14,97% | 16,88 mld. | |
-39,94% | 16,87 mld. | |
+2,80% | 13,63 mld. | |
+27,39% | 11,61 mld. |